Urothelial cancer prognosis worse for smokers, particularly women

Risk of developing serious forms of urothelial carcinoma is significantly increased in smokers and leads to a higher likelihood of dying from the disease, especially for women.

Carriers of Lynch syndrome have two-fold increased risk of prostate cancer

A JCO study has found that Lynch syndrome carriers have an almost two-fold cumulative chance of prostate cancer at ages 60 and 80 years.

Three biomarkers can detect kidney cancer with high accuracy

Levels of three serum proteins are much higher in kidney cancer patients, lending a highly accurate diagnosis.

Lynch-related endometrial cancer raises risk of other cancers

Women with Lynch syndrome and endometrial cancer have elevated risks for several other cancers, including breast, bladder, and kidney cancers.

Low-risk bladder cancer rarely progresses to muscle invasion

Although low-risk bladder cancer rarely escalates to muscle invasion, it is associated with an increased risk of disease-specific mortality compared with the general population.

Analysis explores best use of radical prostatectomy vs watchful waiting

Researchers assessed why two studies comparing prostatectomy with watchful waiting had conflicting findings in absolute mortality difference.

Mucosal vaccination may be best route for fighting head, neck tumors

Therapeutic vaccines for mucosal cancers may work best when administered directly at the site of those tumors rather than elsewhere.

Study results support patient concerns about a controversial side effect of therapy

A posttreatment assessment of men who underwent treatment for prostate cancer revealed a side effect that has a significant impact on patients.

Clinical Trial: Atkins Diet and Prostate Cancer Clinical Trial

Clinical Trial: Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery.

Clinical Trial: Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

Clinical Trial: Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Clinical Trial: Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)